Beximco Pharma (BXP.L*): Plans to begin producing remdesivir (Source: Reuters) | Microsaic Systems (MSYS.L): COVID-19 update | Creo Medical (CREO.L): Final results for the 12 months ended 31 December 2019
07 May 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 39.0 | Microsaic Systems plc (MSYS:LON), 1.2 | Creo Medical Group Plc (CREO:LON), 34.2
- Published:
07 May 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Beximco Pharma (BXP.L*): Plans to begin producing remdesivir (Source: Reuters) | Microsaic Systems (MSYS.L): COVID-19 update | Creo Medical (CREO.L): Final results for the 12 months ended 31 December 2019